Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Necrostatin-1

Inhibits necroptosis
 
BML-AP309-0020 20 mg 84.00 USD
 
BML-AP309-0100 100 mg 327.00 USD
 
Replaces Prod. #: ALX-430-136

Necrostatin-1 inhibits necroptosis, a non-apoptotic cell death pathway. Inhibits the loss of mitochondrial membrane potential in TNFα-treated Jurkat cells (EC50=490 nM). Does not inhibit FAS-induced apoptosis and has no effect on apoptotic morphology. It displays a pronounced protective effect in a mouse model of ischemic brain injury and inhibits myocardial cell death. Inhibits RIP1 kinase the key upstream kinase involved in the activation of necroptosis (EC50=180nM).

Product Specification

Alternative Name:Methylthiohydantoin-DL-tryptophan
 
Formula:C13H13N3OS
 
MW:259.3
 
CAS:4311-88-0
 
Purity:≥98% (TLC)
 
Appearance:Yellow solid.
 
Solubility:Soluble in DMSO (20mg/ml) or 100% ethanol (5mg/ml).
 
Long Term Storage:Ambient
 
Use/Stability:Stock solutions are stable for up to 3 months when stored at -20°C.
 
Handling:Protect from light.
 
bml-ap309
Please mouse over
bml-ap309

Product Literature References

Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death: K. Moriwaki, et al.; Cell Death Dis. 6, e1636 (2015), Application(s): Cell Culture, Abstract; Full Text
A novel role for the apoptosis inhibitor ARC in suppressing TNFα-induced regulated necrosis: G. Kung, et al.; Cell Death Differ. 21, 634 (2014), Abstract;
TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis: I. Karl, et al.; Cell Death Dis. 5, e1444 (2014), Application(s): Cell death induction in primary keratinocytes, HaCaT and HeLa cells, Abstract; Full Text
The Isopeptidase Inhibitor G5 Triggers a Caspase-independent Necrotic Death in Cells Resistant to Apoptosis: A COMPARATIVE STUDY WITH THE PROTEASOME INHIBITOR BORTEZOMIB: A. Fontanini et al.; J. Biol. Chem. 284, 8369 (2009), Abstract;
Identification of RIP1 kinase as a specific cellular target of necrostatins: A. Degterev, et al.; Nat. Chem. Biol. 4, 313 (2008), Abstract;
Chemical genetic approaches to probing cell death: B.R. Stockwell & N.M. Gangadhar; Curr. Opin. Chem. Biol. 11, 83 (2007), Abstract;
Clinical aspects of indoleamine 2,3-dioxygenase (IDO)-initiated tryptophan metabolism: IDO is a target of drug discovery for various diseasea: O. Takikawa; Int. Congr. Ser. 1304, 290 (2007),
Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells: X. Xu et al.; J. Neurochem. 103, 2004 (2007), Abstract;
Necrostatin: a potentially novel cardioprotective agent?: C.C. Smith et al.; Cardiovasc. Drugs Ther. 21, 227 (2007), Abstract;
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury: A. Degterev et al.; Nat. Chem. Biol. 1, 112 (2005), Abstract;
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy: A.J. Muller et al.; Nat. Med. 11, 312 (2005), Abstract;

Related Products

Necrostatin-5 

Necroptosis inhibitor
337349-54-9, ≥98% (HPLC, TLC) | Print as PDF
 
ALX-430-169-M005 5 mg 46.00 USD
 
ALX-430-169-M025 25 mg 183.00 USD
 

Product Toolbox

PRODUCT RESOURCES

Print as PDF
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
RIP
By biological activity:
RIP Inhibitor
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Bulk Quantity Quote
Customer Service

Related Literature

Product Flyers
Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling 10-Oct-12
Download as PDF

Product Flyers
Necrosis & Necroptosis Inhibitors
Necrosis & Necroptosis Inhibitors 08-Jun-10
Download as PDF

Scientific Posters
Disease-Associated Stress Signaling
Disease-Associated Stress Signaling 20-Sep-10
Download as PDF

All new literature pieces

Recommend this page

 
Keep in touch

©2015 Enzo Life Sciences, Inc.,